Spotlight: Dr. David Hill, a change advocateLeader at the forefront of pharmacy evolution in Canada. Trends and Insights: Going CoastalWhat’s on the minds of pharmacists across the country? Wiping out acne Helping patients gain control. Nevanac: new ophthalmic NSAID coming soon Forteo approved for severe steroid-induced osteoporosis Codeine too risky for breastfed infants Coming soon: new IV cephalosporin active against MRSA CVS Caremark to acquire Longs Drug Stores Chronic disease management report highlights collaboration Saskatchewan project largest of its kind in Canada. Drug News: July/August 2008 Stalevo: new combo for Parkinson’s disease; Vectibix for colorectal cancer. Editorial: Blue skies ahead Blueprint for Pharmacy a chance to collectively move the profession forward. Practice Issues: Adverse Reactions - ESAs for cancer-related anemia Trials assess ESA use for the treatment of anemia among patients with cancer. First Previous 1065 1066 1067 1068 1069 Next Last
